Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.

MKEA

EURONEXT:MKEA

Mauna Kea Technologies SA

Last Close

0.62

07/08 14:09

Market Cap

30.17M

Beta: 1.60

Volume Today

9.88K

Avg: 221.67K

PE Ratio

−2.48

PFCF: −3.36

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics